Published in Bone on May 01, 2001
Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res (2009) 3.53
BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res (2006) 1.91
Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol (2006) 1.28
BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity. J Biol Chem (2010) 1.22
Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization. Mol Biol Cell (2010) 1.18
BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells (2013) 1.17
Reconciling the roles of FAK in osteoblast differentiation, osteoclast remodeling, and bone regeneration. Bone (2007) 1.12
p38 MAPK regulates IL-1beta induced IL-6 expression through mRNA stability in osteoblasts. Immunol Invest (2004) 1.12
Receptor oligomerization and beyond: a case study in bone morphogenetic proteins. BMC Biol (2009) 1.12
Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts. J Bone Miner Res (2007) 1.11
The role of NELL-1, a growth factor associated with craniosynostosis, in promoting bone regeneration. J Dent Res (2010) 1.11
Bone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2. J Biol Chem (2008) 1.05
Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity. Proc Natl Acad Sci U S A (2010) 1.03
P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One (2012) 0.97
BMP4 is a novel paracrine inhibitor of liver regeneration. Am J Physiol Gastrointest Liver Physiol (2012) 0.95
Phosphate and vascular calcification: Emerging role of the sodium-dependent phosphate co-transporter PiT-1. Thromb Haemost (2010) 0.94
Palate morphogenesis: current understanding and future directions. Birth Defects Res C Embryo Today (2010) 0.94
A review of crosstalk between MAPK and Wnt signals and its impact on cartilage regeneration. Cell Tissue Res (2014) 0.91
Sesamin stimulates osteoblast differentiation through p38 and ERK1/2 MAPK signaling pathways. BMC Complement Altern Med (2012) 0.91
Nuclear variants of bone morphogenetic proteins. BMC Cell Biol (2010) 0.89
BMP signaling in mesenchymal stem cell differentiation and bone formation. J Biomed Sci Eng (2013) 0.89
Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2. Biomaterials (2014) 0.88
Inhibition of CK2 binding to BMPRIa induces C2C12 differentiation into osteoblasts and adipocytes. J Cell Commun Signal (2013) 0.87
Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma. Leukemia (2012) 0.87
Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells. Tissue Eng Part A (2010) 0.87
SMAD versus non-SMAD signaling is determined by lateral mobility of bone morphogenetic protein (BMP) receptors. J Biol Chem (2012) 0.87
NELL-1-dependent mineralisation of Saos-2 human osteosarcoma cells is mediated via c-Jun N-terminal kinase pathway activation. Int Orthop (2012) 0.82
p38 MAPK Signaling in Osteoblast Differentiation. Front Cell Dev Biol (2016) 0.82
BMP signaling dynamics in embryonic orofacial tissue. J Cell Physiol (2008) 0.81
Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy. Cell Mol Life Sci (2012) 0.80
Activation of JNKs is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells. BMB Rep (2013) 0.80
Expression profiling of transforming growth factor beta superfamily genes in developing orofacial tissue. Birth Defects Res A Clin Mol Teratol (2006) 0.79
Recombinant biglycan promotes bone morphogenetic protein-induced osteogenesis. J Dent Res (2014) 0.78
Differential effects of short term feeding of a soy protein isolate diet and estrogen treatment on bone in the pre-pubertal rat. PLoS One (2012) 0.78
The role of bone morphogenetic proteins in ankylosing spondylitis. Ther Adv Musculoskelet Dis (2012) 0.78
Rap1A Regulates Osteoblastic Differentiation via the ERK and p38 Mediated Signaling. PLoS One (2015) 0.78
FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts. Stem Cell Rev (2012) 0.77
Stiffness-dependent cellular internalization of matrix-bound BMP-2 and its relation to Smad and non-Smad signaling. Acta Biomater (2016) 0.77
BMPR2-pSMAD1/5 signaling pathway regulates RUNX2 expression and impacts the progression of dedifferentiated chondrosarcoma. Am J Cancer Res (2016) 0.76
Quinoline compound KM11073 enhances BMP-2-dependent osteogenic differentiation of C2C12 cells via activation of p38 signaling and exhibits in vivo bone forming activity. PLoS One (2015) 0.76
The mechanism of a chitosan-collagen composite film used as biomaterial support for MC3T3-E1 cell differentiation. Sci Rep (2016) 0.75
Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Mol Med Rep (2015) 0.75
Bone Morphogenetic Protein-9 Enhances Osteogenic Differentiation of Human Periodontal Ligament Stem Cells via the JNK Pathway. PLoS One (2017) 0.75
Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation. J Bone Miner Metab (2014) 0.75
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
The effects of reciprocal changes in temperature on the transformed state of cells infected with a rous sarcoma virus mutant. Virology (1971) 7.83
Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem (1999) 5.81
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain (2006) 5.55
Recovery of avian sarcoma virus from tumors induced by transformation-defective mutants. J Exp Med (1977) 4.79
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol (2010) 4.55
Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A (1997) 4.25
Genetic recombination with avian tumor virus. Virology (1972) 4.23
The erbB gene of avian erythroblastosis virus is a member of the src gene family. Cell (1983) 3.82
Location of envelope-specific and sarcoma-specific oligonucleotides on RNA of Schmidt-Ruppin Rous sarcoma virus. Proc Natl Acad Sci U S A (1976) 3.73
Characterization of Y73, an avian sarcoma virus: a unique transforming gene and its product, a phosphopolyprotein with protein kinase activity. Proc Natl Acad Sci U S A (1980) 3.58
Isolation of defective mutant of avian sarcoma virus. Proc Natl Acad Sci U S A (1973) 3.38
Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest (2001) 3.37
A functional link between dynamin and the actin cytoskeleton at podosomes. J Cell Biol (2000) 3.12
Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun (1999) 3.03
Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biochemical properties of mutant TK15 and mutant-induced transformants. J Virol (1984) 2.95
Complex Regional Pain Syndromes: guidelines for therapy. Clin J Pain (1998) 2.90
Spred is a Sprouty-related suppressor of Ras signalling. Nature (2001) 2.87
Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol (1985) 2.73
Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol (2001) 2.69
Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med (2000) 2.61
Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci U S A (1996) 2.53
Unifected avian cells contain structurally unrelated progenitors of viral sarcoma genes. Nature (1980) 2.50
Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology (1998) 2.48
Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology (1999) 2.47
Transformation-defective mutants of Rous sarcoma virus with src gene deletions of varying length. J Virol (1977) 2.43
RNA of replication-defective strains of Rous sarcoma virus. Proc Natl Acad Sci U S A (1975) 2.37
Isolation of different kinds of non-virus producing chick cells transformed by Schmidt-Ruppin strain (subgroup A) of Rous sarcoma virus. Jpn J Exp Med (1970) 2.35
v-maf, a viral oncogene that encodes a "leucine zipper" motif. Proc Natl Acad Sci U S A (1989) 2.24
Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res (1993) 2.22
Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem (1999) 2.21
c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature (1996) 2.20
Two cellular proteins that immunoprecipitate with the transforming protein of Rous sarcoma virus. Virology (1981) 2.16
Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone (2002) 2.13
Sequence variation in the 18S rRNA gene, a target for PCR-based malaria diagnosis, in Plasmodium ovale from southern Vietnam. J Clin Microbiol (1996) 2.12
Anti-glomerular-basement-membrane disease after lithotripsy. Lancet (1990) 2.11
Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis (2008) 2.11
An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol (1992) 2.03
Dynamic mechanical allodynia in humans is not mediated by a central presynaptic interaction of A beta-mechanoreceptive and nociceptive C-afferents. Pain (1999) 2.01
Performance characteristics according to playing position in elite soccer. Int J Sports Med (2006) 1.99
Free vascularized thin corticoperiosteal graft. Plast Reconstr Surg (1991) 1.98
A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas. Cell (1983) 1.95
Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J Cell Biol (1997) 1.87
Plaque assay for some strains of avian leukosis virus. Virology (1972) 1.87
A cellular protein is immunologically crossreactive with and functionally homologous to the Fujinami sarcoma virus transforming protein. Cell (1982) 1.86
Genome structure of avian sarcoma virus Y73 and unique sequence coding for polyprotein p90. J Virol (1981) 1.85
Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis. Arthritis Rheum (1999) 1.85
Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biological properties of mutant TK15 and mutant-induced transformants. J Virol (1984) 1.83
LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med (1990) 1.83
Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. Arch Neurol (1999) 1.78
Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol (2000) 1.77
Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol (2007) 1.77
Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J Biol Chem (2001) 1.76
A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes. Eur J Immunol (1988) 1.76
Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci (2001) 1.74
Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest (1999) 1.73
Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest (2000) 1.70
Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A. Virology (1988) 1.70
Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem (1994) 1.70
Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab (1982) 1.68
A physiological profile of tennis match play. Med Sci Sports Exerc (2001) 1.68
Osteoclasts express high levels of pp60c-src in association with intracellular membranes. J Cell Biol (1992) 1.67
The relationship between isokinetic quadriceps strength test and hop tests for distance and one-legged vertical jump test following anterior cruciate ligament reconstruction. J Orthop Sports Phys Ther (1998) 1.63
EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol (2010) 1.63
Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc Natl Acad Sci U S A (1998) 1.63
Detection of a raf-related and two other transforming DNA sequences in human tumors maintained in nude mice. Proc Natl Acad Sci U S A (1985) 1.61
Interleukin-1 beta converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J (1995) 1.60
Transformation of rat cells by fusion-infection with Rous sarcoma virus. J Virol (1980) 1.60
The increased bone mass in deltaFosB transgenic mice is independent of circulating leptin levels. Endocrinology (2002) 1.59
The effect of current direction induced by transcranial magnetic stimulation on the corticospinal excitability in human brain. Electroencephalogr Clin Neurophysiol (1996) 1.56
Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest (2000) 1.54
Successful treatment of a hepatic abscess that formed secondary to fish bone penetration by percutaneous transhepatic removal of the foreign body: report of a case. Surg Today (1999) 1.54
Presence of antigen common to avian tumor viral envelope antigen in normal chick embryo cells. Virology (1973) 1.54
Studies on the human T cell receptor alpha/beta variable region genes. II. Identification of four additional V beta subfamilies. Eur J Immunol (1991) 1.53
A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells: application to the characterization of serum response element binding proteins during osteoclast differentiation. J Bone Miner Res (1998) 1.52
A bacterial enzyme degrading the model lignin compound beta-etherase is a member of the glutathione-S-transferase superfamily. FEBS Lett (1993) 1.52
Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. Br J Surg (2008) 1.50
Evaluation of a screening test for detecting urinary tract infection in newborns and infants. J Clin Pathol (1991) 1.48
Antibody to phosphatidylinositol 4,5-bisphosphate inhibits oncogene-induced mitogenesis. Proc Natl Acad Sci U S A (1988) 1.48
Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis (1998) 1.47
Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem (1995) 1.47
Cushing's syndrome due to primary adrenocortical nodular dysplasia, cardiac myxomas, and spotty pigmentation, complicated by sarcoidosis. Intern Med (1992) 1.46
Arrhythmogenic right ventricular cardiomyopathy with an initial manifestation of severe left ventricular impairment and normal contraction of the right ventricle. Jpn Circ J (2000) 1.46
Cloning and sequencing of the gene for a Pseudomonas paucimobilis enzyme that cleaves beta-aryl ether. J Bacteriol (1991) 1.44
Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family. J Virol (1993) 1.43
Mitogenesis in response to PDGF and bombesin abolished by microinjection of antibody to PIP2. Science (1988) 1.43
Clinical application of the perineal scan: prepartum screening for cord presentation. Am J Obstet Gynecol (1986) 1.42
Contributions and co-ordination of individual fingers in multiple finger prehension. Ergonomics (1995) 1.41
Dynamic histomorphometry of alveolar bone remodeling in the adult rat. Anat Rec (1980) 1.40
18 years mitotane therapy for intractable Cushing's disease. Lancet (1999) 1.39